Can the total thrombus-formation analysis system predict bleeding risk in individuals with VWF levels between 30 and 50 IU/dL?
Thromb Res
.
2025 Jan 16:247:109260.
doi: 10.1016/j.thromres.2025.109260.
Online ahead of print.
Authors
Nuria Revilla
1
,
Rosa Vidal-Laso
2
,
Diego Velasco-Rodríguez
2
,
Inés Martínez-Alfonzo
2
,
Sara Martín-Herrero
2
,
Bárbara Hernández
3
,
Pilar Llamas
2
Affiliations
1
Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain. Electronic address: nuria.revilla@quironsalud.es.
2
Hematology Department, Hospital Universitario Fundación Jiménez Díaz, Instituto de Investigación Fundación Jiménez Díaz (IIS-FJD), Madrid, Spain.
3
Pediatrician Department, Hospital Universitario Fundación Jiménez Díaz, IIS-FJD, Madrid, Spain.
PMID:
39842330
DOI:
10.1016/j.thromres.2025.109260
No abstract available
Keywords:
Desmopressin; Low VWF; T-TAS; VWD; Willebrand.
Publication types
Letter